AAAAAA
Results: 1-25/34
Authors:
Gao, AC
Isaacs, JT
Citation: Ac. Gao et Jt. Isaacs, The molecular basis of prostate carcinogenesis, MOLECULAR BASIS OF HUMAN CANCER, 2002, pp. 365-378
Authors:
Kurita, T
Wang, YZ
Donjacour, AA
Zhao, C
Lydon, JP
O'Malley, BW
Isaacs, JT
Dahiya, R
Cunha, GR
Citation: T. Kurita et al., Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system, CELL DEAT D, 8(2), 2001, pp. 192-200
Authors:
Weeraratna, AT
Dalrymple, SL
Lamb, JC
Denmeade, SR
Miknyoczki, S
Dionne, CA
Isaacs, JT
Citation: At. Weeraratna et al., Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells, CLIN CANC R, 7(8), 2001, pp. 2237-2245
Authors:
Chen, CS
Brabham, WW
Stultz, BG
Frierson, HF
Barrett, JC
Sawyers, CL
Isaacs, JT
Dong, JT
Citation: Cs. Chen et al., Defining a common region of deletion at 13q21 in human cancers, GENE CHROM, 31(4), 2001, pp. 333-344
Authors:
Khan, SR
Mhaka, A
Pili, R
Isaacs, JT
Citation: Sr. Khan et al., Modified synthesis and antiangiogenic activity of Linomide, BIOORG MED, 11(4), 2001, pp. 451-452
Authors:
Isaacs, JT
Bartsch, G
Isaacs, WB
Citation: Jt. Isaacs et al., From the editorial office, PROSTATE, 48(3), 2001, pp. 127-127
Authors:
Gao, J
Isaacs, JT
Citation: J. Gao et Jt. Isaacs, Mixed lineage kinase (MLK) family members are not involved in androgen regulation of prostatic proliferation or apoptosis, PROSTATE, 48(2), 2001, pp. 67-70
Authors:
Keledjian, K
Borkowski, A
Kim, G
Isaacs, JT
Jacobs, SC
Kyprianou, N
Citation: K. Keledjian et al., Reduction of human prostate tumor vascularity by the alpha 1-adrenoceptor antagonist terazosin, PROSTATE, 48(2), 2001, pp. 71-78
Authors:
Denmeade, SR
Lovgren, J
Khan, SR
Lilja, H
Isaacs, JT
Citation: Sr. Denmeade et al., Activation of latent protease function of Pro-HK2, but not Pro-PSA, involves autoprocessing, PROSTATE, 48(2), 2001, pp. 122-126
Authors:
Denmeade, SR
Sokoll, LJ
Chan, DW
Khan, SR
Isaacs, JT
Citation: Sr. Denmeade et al., Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostatecancer xenograft models, PROSTATE, 48(1), 2001, pp. 1-6
Authors:
Isaacs, JT
Citation: Jt. Isaacs, Untitled, PROSTATE, 46(1), 2001, pp. 1-1
Authors:
Pinski, J
Parikh, A
Bova, GS
Isaacs, JT
Citation: J. Pinski et al., Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts, CANCER RES, 61(17), 2001, pp. 6372-6376
Authors:
Gao, J
Arnold, JT
Isaacs, JT
Citation: J. Gao et al., Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells, CANCER RES, 61(13), 2001, pp. 5038-5044
Authors:
Joseph, IBJK
Isaacs, JT
Citation: Ibjk. Joseph et Jt. Isaacs, Angiogenesis and prostate cancer, CONT CANC R, 2001, pp. 279-306
Authors:
Isaacs, JT
Citation: Jt. Isaacs, Apoptosis: Translating theory to therapy for prostate cancer, J NAT CANC, 92(17), 2000, pp. 1367-1369
Authors:
Gao, AC
Lou, W
Isaacs, JT
Citation: Ac. Gao et al., Enhanced GBX2 expression stimulates growth of human prostate cancer cells via transcriptional up-regulation of the interleukin 6 gene, CLIN CANC R, 6(2), 2000, pp. 493-497
Mapping of metastasis suppressor genes for prostate cancer by microcell-mediated chromosome transfer
Authors:
Ichikawa, T
Hosoki, S
Suzuki, H
Akakura, K
Igarashi, T
Furuya, Y
Oshimura, M
Rinker-Schaeffer, CW
Nihei, N
Barrett, JC
Isaacs, JT
Ito, H
Citation: T. Ichikawa et al., Mapping of metastasis suppressor genes for prostate cancer by microcell-mediated chromosome transfer, ASIAN J AND, 2(3), 2000, pp. 167-171
Authors:
Lapidus, RG
Tiffany, CW
Isaacs, JT
Slusher, BS
Citation: Rg. Lapidus et al., Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells, PROSTATE, 45(4), 2000, pp. 350-354
Authors:
Isaacs, JT
Citation: Jt. Isaacs, Gerald P. Murphy - In memoriam, PROSTATE, 45(2), 2000, pp. 85-86
Authors:
Weeraratna, AT
Arnold, JT
George, DJ
DeMarzo, A
Isaacs, JT
Citation: At. Weeraratna et al., Rational basis for trk inhibition therapy for prostate cancer, PROSTATE, 45(2), 2000, pp. 140-148
Authors:
Tombal, B
Weeraratna, AT
Denmeade, SR
Isaacs, JT
Citation: B. Tombal et al., Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells, PROSTATE, 43(4), 2000, pp. 303-317
Authors:
Dong, JT
Chen, C
Stultz, BG
Isaacs, JT
Frierson, HF
Citation: Jt. Dong et al., Deletion at 13q21 is associated with aggressive prostate cancers, CANCER RES, 60(14), 2000, pp. 3880-3883
Authors:
Joseph, IBJK
Isaacs, JT
Citation: Ibjk. Joseph et Jt. Isaacs, Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents - Reply, J NAT CANC, 91(9), 1999, pp. 805-806
Authors:
Christensen, SB
Andersen, A
Kromann, H
Treiman, M
Tombal, B
Denmeade, S
Isaacs, JT
Citation: Sb. Christensen et al., Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells, BIO MED CH, 7(7), 1999, pp. 1273-1280
Authors:
Isaacs, JT
Citation: Jt. Isaacs, Dr. Donald Straley Coffey - Preface, PROSTATE, 39(4), 1999, pp. 223-225